» Articles » PMID: 26100458

Treating Elderly Patients with ANCA-associated Vasculitis

Overview
Specialty Nephrology
Date 2015 Jun 24
PMID 26100458
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

ANCA-associated vasculitis and the impact of diffuse alveolar hemorrhage in elderly patients: a retrospective cohort study.

Schaier M, Kalble F, Benning L, Reichel P, Mahler C, Nusshag C Rheumatol Int. 2025; 45(3):68.

PMID: 40029448 PMC: 11876205. DOI: 10.1007/s00296-025-05812-8.


Diagnosis and Treatment of Renal ANCA Vasculitis: A Summary of the Consensus Document of the Catalan Group for the Study of Glomerular Diseases (GLOMCAT).

Draibe J, Marco H, Ibernon M, Agraz I, Arcal C, Barros X J Clin Med. 2024; 13(22).

PMID: 39597938 PMC: 11594726. DOI: 10.3390/jcm13226793.


Assessment of cardiovascular risk in patients with ANCA-associated vasculitis: A systematic review and meta-analysis.

Goyal A, Abbasi H, Mashkoor Y, Khan A, Sulaiman S, Daoud M Int J Cardiol Cardiovasc Risk Prev. 2024; 23:200334.

PMID: 39417001 PMC: 11481614. DOI: 10.1016/j.ijcrp.2024.200334.


General prognostic models may neglect vulnerable subgroups in ANCA-associated vasculitis.

Russwurm M, Kortus-Goetze B, Maier-Giebing T, Groene H, Hoyer J J Nephrol. 2023; 36(8):2269-2280.

PMID: 37768548 PMC: 10638135. DOI: 10.1007/s40620-023-01726-5.


[Treatment response and complications of older patients with ANCA(antineutrophil cytoplasmatic antibody)-associated vasculitis].

Schulte-Kemna L, Kuhne D, Bettac L, Herrmann H, Ludwig U, Kachele M Z Gerontol Geriatr. 2022; 56(8):661-666.

PMID: 36534140 PMC: 10709238. DOI: 10.1007/s00391-022-02145-0.


References
1.
Stone J, Merkel P, Spiera R, Seo P, Langford C, Hoffman G . Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010; 363(3):221-32. PMC: 3137658. DOI: 10.1056/NEJMoa0909905. View

2.
Jones R, Cohen Tervaert J, Hauser T, Luqmani R, Morgan M, Peh C . Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010; 363(3):211-20. DOI: 10.1056/NEJMoa0909169. View

3.
Lyons P, Rayner T, Trivedi S, Holle J, Watts R, Jayne D . Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012; 367(3):214-23. PMC: 3773907. DOI: 10.1056/NEJMoa1108735. View

4.
Lionaki S, Blyth E, Hogan S, Hu Y, Senior B, Jennette C . Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum. 2012; 64(10):3452-62. PMC: 3462364. DOI: 10.1002/art.34562. View

5.
Jennette J, Falk R, Bacon P, Basu N, Cid M, Ferrario F . 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2012; 65(1):1-11. DOI: 10.1002/art.37715. View